GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MyunMoon Pharm Co Ltd (XKRX:017180) » Definitions » Market Cap

MyunMoon Pharm Co (XKRX:017180) Market Cap : ₩53,352 Mil (As of Mar. 25, 2025)


View and export this data going back to 2008. Start your Free Trial

What is MyunMoon Pharm Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MyunMoon Pharm Co's share price for the quarter that ended in Dec. 2024 was ₩1819. MyunMoon Pharm Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 33 Mil. Therefore, MyunMoon Pharm Co's market cap for the quarter that ended in Dec. 2024 was ₩60,806 Mil.

MyunMoon Pharm Co's quarterly market cap increased from Jun. 2024 (₩66,685 Mil) to Sep. 2024 (₩71,035 Mil) but then declined from Sep. 2024 (₩71,035 Mil) to Dec. 2024 (₩60,806 Mil).

MyunMoon Pharm Co's annual market cap declined from Dec. 2022 (₩97,023 Mil) to Dec. 2023 (₩76,609 Mil) and declined from Dec. 2023 (₩76,609 Mil) to Dec. 2024 (₩60,806 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MyunMoon Pharm Co's Enterprise Value for Today is ₩140,952 Mil.


MyunMoon Pharm Co Market Cap Historical Data

The historical data trend for MyunMoon Pharm Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyunMoon Pharm Co Market Cap Chart

MyunMoon Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 245,769.62 159,902.38 97,023.22 76,609.20 60,805.53

MyunMoon Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76,609.20 76,944.47 66,685.20 71,034.50 60,805.53

Competitive Comparison of MyunMoon Pharm Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, MyunMoon Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MyunMoon Pharm Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MyunMoon Pharm Co's Market Cap distribution charts can be found below:

* The bar in red indicates where MyunMoon Pharm Co's Market Cap falls into.



MyunMoon Pharm Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

MyunMoon Pharm Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=₩1819*33.428
=₩60,806

MyunMoon Pharm Co's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₩1819*33.428
=₩60,806

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyunMoon Pharm Co  (XKRX:017180) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


MyunMoon Pharm Co Market Cap Related Terms

Thank you for viewing the detailed overview of MyunMoon Pharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


MyunMoon Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
946-18 Dokok-Dong, Kangnam-ku, Seoul, KOR, 135-270
MyunMoon Pharm Co Ltd is a South Korea based company engages in the manufacture and sale of pharmaceutical products. Its products include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs, and others.

MyunMoon Pharm Co Headlines

No Headlines